Kastytis C. Karvelis

Phase I/II 90 Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma

Gregory A. Wiseman, Christine A. White, Michael Stabin et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 234 citations

Lymphoid Neoplasia, Radioimmunotherapy Dosimetry Results, Phase I/ii 90 +7

Phase I Study of Noninvasive Imaging of Adenovirus-mediated Gene Expression in the Human Prostate

Kenneth Barton, Hans Stricker, Stephen L. Brown et al. · Molecular Therapy · 2008 · 140 citations · Full text

An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial

Stephen B. Tatter, Edward G. Shaw, Mark L. Rosenblum et al. · Journal of neurosurgery · 2003 · 117 citations

Pathways of Lymphatic Drainage From the Breast

S. David Nathanson, D. Lynne Wachna, Donna Gilman et al. · Annals of Surgical Oncology · 2001 · 54 citations

Histopathology, Pathology, Lymphatic System +5

Feasibility of Adenovirus-Mediated hNIS Gene Transfer and 131I Radioiodine Therapy as a Definitive Treatment for Localized Prostate Cancer

Kenneth Barton, Hans Stricker, Mohamed A. Elshaikh et al. · Molecular Therapy · 2011 · 51 citations · Full text